ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 168 filers reported holding ARCELLX INC in Q2 2024. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,114,398 | -30.1% | 20,192 | -11.9% | 0.02% | -25.0% |
| Q1 2024 | $1,594,922 | +5.9% | 22,932 | -15.5% | 0.03% | +3.2% |
| Q4 2023 | $1,505,937 | +56.1% | 27,134 | +0.9% | 0.03% | +55.0% |
| Q3 2023 | $964,563 | +50.8% | 26,883 | +32.9% | 0.02% | +53.8% |
| Q2 2023 | $639,610 | – | 20,228 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $124,792,441 | 53.81% |
| NEA Management Company, LLC | 3,745,262 | $118,425,184 | 9.04% |
| Paradigm Biocapital Advisors LP | 2,347,000 | $74,212,140 | 5.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,848,167 | $90,059,041 | 4.82% |
| Perceptive Advisors | 4,016,397 | $126,998,473 | 3.68% |
| Cormorant Asset Management, LP | 2,000,000 | $63,240,000 | 3.54% |
| Soleus Capital Management, L.P. | 1,001,999 | $31,683,208 | 3.52% |
| Samsara BioCapital, LLC | 613,921 | $19,412,182 | 3.41% |
| Affinity Asset Advisors, LLC | 226,275 | $7,154,816 | 2.50% |
| Novo Holdings A/S | 1,000,000 | $31,620,000 | 2.44% |